Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
20 September 2021 | Story Leonie Bolleurs | Photo Supplied
Prince Matova, a PhD student in the Department of Plant Sciences, has been working on breeding a maize that can resist the fall armyworm (FAW) – a maize-eating pest. Later in September, he will receive the Young Scientist Award from the Plant Mutation Breeding Division of the International Atomic Energy Agency (IAEA) and the Food and Agriculture Organisation of the United Nations (FAO).

Prince Matova, a PhD student in Plant Breeding at the University of the Free State (UFS), received the Young Scientist Award from the Joint Food and Agriculture Organisation of the United Nations (FAO)/International Atomic Energy Agency (IAEA) Division of Nuclear Techniques in Food and Agriculture for excellence in plant mutation breeding.

The IAEA Director-General, Mr Rafael Mariano Grossi, will officially announce the award at the 65th regular session of the IAEA General Conference that will take place later in September this year.

The award is given to scientists younger than 40, who have made a significant contribution and impact in the field of mutation breeding.

Matova, a researcher, research and agronomy manager, and maize and legumes breeder at Mukushi Seeds (Pvt) Ltd in Harare, Zimbabwe, says: “People have seen the little work that I have done, and they were happy with it. That makes me happy too.”

Other contributions

In the ten years collaborating with the IAEA, practising mutation breeding, Matova – who believes innovative thinking and self-motivation to be contributing factors to a successful scientist – has also been recognised for other outstanding contributions. These include the release of a cowpea mutant variety in 2017 and its wide dissemination across Zimbabwe, as well as the modernisation of the maize and cowpea national breeding programmes. He has also contributed two publications and appeared twice at IAEA Plant Mutation Breeding symposia. Furthermore, Matova has trained other scientists and fellows across Africa and collaborated with centres of excellence in plant breeding, research, and development.

Growing up, he never guessed that he would one day become an agricultural scientist. Matova was, however, very good at biology and believes that this is one of the reasons why he ended up in crop science. “I am enjoying every moment of it. I love innovativeness and inventions and I view hybrid maize variety development as the greatest innovation in plant breeding. Working for Mukushi Seeds is inspiring; I have a young and dedicated team and the environment allows me to explore my full potential.”

“I feel science solves problems and every day as I do my breeding work, I have this desire to achieve greatness by developing a super maize hybrid,” he says.

Displaying excellence

For the past three to four years, Matova has been working to breed maize varieties that can resist fall armyworm (FAW) – a maize-eating pest. He says the pest has caused significant maize crop yield and economic losses across Africa.

More than 300 million smallholder farmers across sub-Saharan Africa rely on maize for food and livelihoods. “These farmers have limited capacities to control the pest. They are using insecticides, which we have seen to effectively provide immediate control of the pest.” However, these pesticides have environmental and health issues. “It is against this background that we, as plant breeders, felt it was important to develop varieties that are resistant to the pest. It is a more environmentally friendly, less expensive, and more sustainable solution,” explains Matova.
In his research, he evaluated the breeding potential of exotic FAW-resistant donor lines with local lines. He also investigated the resistance response and stability of local cultivars and inbred lines against FAW. 

While working at the Zimbabwean Department of Research and Specialist Services (DR&SS), Matova collaborated with the International Maize and Wheat Improvement Center (CIMMYT), the University of Zimbabwe, the UFS, and the IAEA to look into the possibility of using mutation breeding in maize crop improvement, with the intention to enhance FAW-resistance in maize genotypes.

He introgressed FAW resistance into the elite breeding materials at both DR&SS and Mukushi Seeds, where he is currently working. Matova believes that although FAW resistance is currently a nice-to-have trait, going forward, all maize varieties released should have a baseline resistance to FAW.

Ultimately, his work generated important information that can guide research and maize breeding for FAW resistance in Southern Africa. All this information is free for researchers to use for the betterment of Africa and the world.

Inspired by greatness

There are a number of people in the industry and academia who have inspired Matova. The list includes Dr Cosmos Magorokosho (CIMMYT), Prof Hussein Shimelis (University of KwaZulu-Natal), Dr Fatma Sarsu (IAEA), Dr Marilyn Warburton (Agricultural Research Service in the United States Department of Agriculture), Dr Amsal Terekegne (ZAMSEED), and Dr John MacRobert (Mukushi Seeds). They all contributed in one way or another to influence Matova in a positive way towards becoming the passionate scientist he is today.

Besides this list of prominent names, Matova says that he was more recently also motivated and encouraged by his PhD supervisor and mentor, Prof Maryke Labuschagne, Professor in Plant Sciences at the UFS. “She is a very special person doing a wonderful job. Prof Labuschagne is kind, thorough, hardworking, and a good mentor,” he states.

Prof Labuschagne is very proud of Matova for receiving this award. “He has been working really hard, and this is a wonderful recognition of the time and effort that he has invested in his research,” she says.


News Archive

Conference: Expanded ARV treatment
2005-03-02

VENUE: University of the Free State, Bloemfontein, South Africa
DATE: 30 March 2005 - 1 April 2005

  • ARV Programme as on 24Feb Download Word document
     
  • Programme Special events Download Word document


    Official web site www.fshealth.gov.za/subsites/arvc

     


    Rationale for the Conference
    At the time of the planned Conference, much ground would have been covered, both in the Free State and in South Africa, in respect of the expanded public sector ARV treatment programme in respect of research, experiences in practice, training of staff, treatment of patients, lessons learned, successes and failures, etc. The time would then be quite opportune to share these in a systematic manner with other provinces and countries, as well as with the large variety of stakeholders and role players in the ARV and related domains, be they academics and researchers, policy makers and service/facility managers, the variety of caregivers, and the community organisations and affected patients.

The Conference and current research
The proposed Conference is, firstly, directly linked to the current research on the public sector roll-out of ARV treatment in the Free State conducted by several research institutions (e.g. CIET, CHSR&D, UCT Lung Institute). Secondly, the Conference could and would serve as a forum for other research groups in the country and further a field to report and share knowledge and experiences on ARV treatment and related initiatives. Lastly, the Conference will stage a golden opportunity for researchers and scientists, on the one hand, and policy makers, managers, and caregivers (as knowledge users), on the other hand, to engage in cross-disciplinary discourse on this mutual and topical theme.

Theme of Conference
Expanded ARV treatment in the Free State: sharing experiences

Focus
The focus is primarily on public sector ARV treatment in the Free State, but also initiatives/activities/perspectives of relevance to the Free State elsewhere in the country at large and further a field, as well as relevant ARV initiatives in the public, private, NGO and FBO sectors. Bear in mind, however, that ARV treatment is but part of a much more comprehensive approach to HIV and AIDS. The Conference will, therefore, not narrowly focus on the ARV treatment programme only. The broader context, other relevant dimensions, and a comprehensive approach to the challenges of HIV, AIDS and TB are of equal importance.

The purpose of the Conference
Enhance meaningful exchange, mutual understanding and collaboration among researchers, scientists, policy makers, managers and practitioners in the field of ARV treatment and related fields.

Share experiences in the various spheres of ARV treatment and related spheres (policy, management, practice, research, training, public-private-civil society sectors).

Record, reflect and report on the establishment of the ARV treatment programme in the Free State, and in within the context of the comprehensive HIV/AIDS programme.

Disseminate important research results on ARV treatment and related themes to health policy makers, managers, practitioners, communities and to the research community.

Stimulate discourse among various disciplines and various stakeholders/role players involved in ARV treatment and related programmes.

Sensitise and acquaint researchers to the requirements of policy makers, managers and practitioners in respect of ARV treatment and related fields.

Facilitate the implementation of research results in ARV treatment policy, programmes and practice.

Dissemination of Conference-related information
Information generated during the Conference could feed into policy, management and practice of ARV treatment, the training accompanying such programme, and the existing body of knowledge. After the Conference the information will be disseminated via the Internet and by scientific and popular publications.

Date and duration
Set for 30 & 31 March & 1 April 2005; to commence at 09:00 on the first day (30 March) and to end at 16:30 (1 April) the third day.

Format and scope of Conference
Alternating plenary, parallel sessions and debates focused on topical issues and interest groups. The Conference will strive to be maximally interactive and participative.

Themes and topics to cover:

  • Policy, management and health services/practice (various levels and contexts – clinical treatment, information, IT systems, pharmacy, laboratories, nutrition)
     
  • Research covering all relevant disciplines and diverse dimensions of ARV treatment and related themes
  • Training and evaluation of training
  • Patients, communities and civil society organisations
  • Public, private, NGO, FBO initiatives and partnerships

Emphasis will be on the Free State, however, with of significant involvement from other provinces, SADC countries, and countries further a field. The thrust will be to export lessons and experiences from the Free State, but also to import lessons and experiences from other provinces, countries and sectors.

Presenters
Key presenters from the Free State, other provinces, South Africa, from the private, FBO and NGO sectors, and from several other countries

Delegates
About half of the delegates will be Free State stakeholders and role players (all levels and all contexts). The other half will be role players and stakeholders in the ARV and related fields from other provinces, the national level, and other countries, as well as from the private, public and non-governmental sectors.

Focused workshops
Provision will be made for half-a-day or one-day workshop initiatives on the third day (1 April 2005).

Enquiries
For more information please contact:

Prof Dingie van Rensburg
Centre for Health Systems Research & Development
University of the Free State
PO Box 339
Bloenfontein
SOUTH AFRICA
9300

Contact:
Carin van Vuuren
Conference Organiser
Centre for Health Systems Research & Development
University of the Free State
P.O.Box 339
Bloemfontein
South Africa
9300
Tel +27 (0) 51 401 2181
Fax +27 (0) 51 4480370
Cell 0832932890
e-mail: arvconference.hum@mail.uovs.ac.za

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept